Suppr超能文献

预防措施的问题:输血医学的经验

Problems with precaution: the transfusion medicine experience.

作者信息

Wilson Kumanan, Atkinson Katherine M, Fergusson Dean A, Brown Adalsteinn, Forster Alan, Murphy Malia S Q, Tinmouth Alan T, Keelan Jennifer

机构信息

Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada.

Departments of Medicine, and Epidemiology, Public Health and Preventive Medicine, University of Ottawa, Ottawa, Canada.

出版信息

J Risk Res. 2019;22(2):137-49. doi: 10.1080/13669877.2017.1351478. Epub 2017 Jul 29.

Abstract

The precautionary principle is a dominant paradigm governing risk-based decision-making. Today, there are increasing pressures to re-examine aggressive precautionary approaches, and to assess how the principle should be applied in the modern system. In this paper, we examined three key applications of precautionary approaches in the field of transfusion medicine to provide insight into the risks and benefits of these approaches. The three case studies examined were the donor deferral policies to safeguard against transfusion transmission of human immunodeficiency virus, variant Creutzfeldt-Jacob disease, and, lastly, xenotropic murine leukemia virus-related virus. Characterization of precautionary applications was conducted using an embedded case study design. Our findings indicate that transfusion transmission mitigation strategies have become increasingly aggressive in the face of theoretical risks. In contrast, the review processes for implementation and reversal of precautionary policies have been slow, and historical donor deferral policies are still in place today. Application of precautionary approaches has proved challenging with both benefits and pitfalls. In light of emerging threats to the blood system, policy-makers should consider the implementation of frameworks to guide the appropriate application of precaution in transfusion medicine in the future.

摘要

预防原则是基于风险的决策制定的主导范式。如今,重新审视激进的预防方法以及评估该原则在现代体系中应如何应用的压力与日俱增。在本文中,我们研究了预防方法在输血医学领域的三个关键应用,以深入了解这些方法的风险和益处。所研究的三个案例分别是为防范人类免疫缺陷病毒、变异型克雅氏病以及最后一种嗜异性小鼠白血病病毒相关病毒的输血传播而制定的献血者延期政策。采用嵌入式案例研究设计对预防应用进行了特征描述。我们的研究结果表明,面对理论风险,输血传播缓解策略已变得越来越激进。相比之下,预防政策的实施和撤销审查过程一直很缓慢,而且历史上的献血者延期政策至今仍然有效。事实证明,预防方法的应用既带来了好处,也存在缺陷,颇具挑战性。鉴于血液系统面临的新威胁,政策制定者未来应考虑实施相关框架,以指导预防措施在输血医学中的适当应用。

相似文献

1
Problems with precaution: the transfusion medicine experience.
J Risk Res. 2019;22(2):137-49. doi: 10.1080/13669877.2017.1351478. Epub 2017 Jul 29.
2
A framework for applying the precautionary principle to transfusion safety.
Transfus Med Rev. 2011 Jul;25(3):177-83. doi: 10.1016/j.tmrv.2011.01.004. Epub 2011 Mar 22.
4
The success of precaution? Managing the risk of transfusion transmission of variant Creutzfeldt-Jakob disease.
Transfusion. 2004 Oct;44(10):1475-8. doi: 10.1111/j.1537-2995.2004.04116.x.
6
[The precautionary principle: advantages and risks].
J Chir (Paris). 2001 Apr;138(2):68-80.
9
Three decades of MSM donor deferral policies. What have we learned?
Int J Infect Dis. 2014 Jan;18:1-3. doi: 10.1016/j.ijid.2013.09.016. Epub 2013 Oct 30.
10
[The precaution principle and blood transfusion].
Transfus Clin Biol. 2000 Jun;7(3):220-7. doi: 10.1016/s1246-7820(00)80002-6.

引用本文的文献

1
Effects of communicating uncertainty descriptions in hazard identification, risk characterization, and risk protection.
PLoS One. 2021 Jul 13;16(7):e0253762. doi: 10.1371/journal.pone.0253762. eCollection 2021.
2
Transfusion medicine: Overtime paradigm changes and emerging paradoxes.
Transfus Clin Biol. 2020 Nov;27(4):262-267. doi: 10.1016/j.tracli.2020.10.001. Epub 2020 Oct 6.
3
Neuroethics for Fantasyland or for the Clinic? The Limitations of Speculative Ethics.
Camb Q Healthc Ethics. 2020 Oct;29(4):630-641. doi: 10.1017/S0963180120000377.

本文引用的文献

2
An inventory of concerns behind blood safety policies in five Western countries.
Transfusion. 2015 Dec;55(12):2816-25. doi: 10.1111/trf.13254. Epub 2015 Aug 30.
3
Health economics and outcomes methods in risk-based decision-making for blood safety.
Transfusion. 2015 Aug;55(8):2039-47. doi: 10.1111/trf.13080. Epub 2015 Apr 9.
4
Prions in the urine of patients with variant Creutzfeldt-Jakob disease.
N Engl J Med. 2014 Aug 7;371(6):530-9. doi: 10.1056/NEJMoa1404401.
5
The use of preliminary scientific evidence in public health: a case study of XMRV.
PLoS Med. 2014 Apr 8;11(4):e1001623. doi: 10.1371/journal.pmed.1001623. eCollection 2014 Apr.
7
Three decades of MSM donor deferral policies. What have we learned?
Int J Infect Dis. 2014 Jan;18:1-3. doi: 10.1016/j.ijid.2013.09.016. Epub 2013 Oct 30.
8
Prion diseases as transmissible zoonotic diseases.
Osong Public Health Res Perspect. 2013 Feb;4(1):57-66. doi: 10.1016/j.phrp.2012.12.008.
9
Evidence-Based Policy and Practice Leads to Changes in the Criteria for MSM to Donate Blood.
Transfus Med Hemother. 2013 Jun;40(3):155-8. doi: 10.1159/000351770. Epub 2013 May 17.
10
The rise and fall of XMRV.
Transfus Med. 2013 Jun;23(3):142-51. doi: 10.1111/tme.12049. Epub 2013 May 21.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验